News Quantified

QURE – uniqure n.v. - ordinary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Holzer & Holzer, LLC Reminds QURE Investors of the April 13, 2026 Lead Plaintiff Deadline in the uniQure N.V. Securities Class Action

FDA official calls UniQure's Huntington's disease treatment a failure [Yahoo! Finance]

FDA official calls UniQure's gene therapy a ‘failed' treatment for Huntington's disease [CNBC]

Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm

Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors

-2.2%

MISS

-3.6%

BEAT

4.2%

BEAT

Wells Fargo & Company

Wells Fargo & Company

Form 144 uniQure N.V. Filed by: Potts Jeannette

Form 144 uniQure N.V. Filed by: KLEMT CHRISTIAN

Form 144 uniQure N.V. Filed by: Kapusta Matthew C

Form 4 uniQure N.V. For: Mar 02 Filed by: Kapusta Matthew C

Form 4 uniQure N.V. For: Mar 02 Filed by: KLEMT CHRISTIAN

Top News Gainers

3/13 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 11.2%

6/16 UniQure NV weighs options including sale -Bloomberg [Reuters] 11.2%

10/25 Form 4 uniQure N.V. For: Oct 23 Filed by: Kapusta Matthew C 7.0%

5/10 uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B 7.0%

6/11 Uniqure NV (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at Janney Montgomery Scott. 5.9%

3/24 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.2%

1/31 Form 4 uniQure N.V. For: Jan 31 Filed by: van Deventer Sander 5.1%

5/16 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.3%

5/21 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 3.9%

4/24 Form 4 uniQure N.V. For: Apr 22 Filed by: Kapusta Matthew C 3.8%

Top News Decliners

9/4 uniQure Announces Proposed Public Offering -14.9%

5/12 Uniqure NV (NASDAQ: QURE) was given a new $81.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock. -7.0%

2/25 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.6%

7/29 Q2/2019 6/30/2019 EPS -0.830 ZacksConsensus N/A ActVsEst N/A - N/A -6.2%

9/5 uniQure Announces Pricing of its Public Offering -6.1%

3/6 Form 3/A uniQure N.V. For: Aug 07 Filed by: KLEMT CHRISTIAN -5.8%

1/29 Form 4 uniQure N.V. For: Jan 27 Filed by: Gut Robert -5.8%

3/2 Form 424B5 uniQure N.V. -5.6%

8/23 Form 4 uniQure N.V. For: Aug 21 Filed by: Kapusta Matthew C -5.0%

5/1 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $71.00 price target on the stock. -4.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day